DGKE
Diacylglycerol kinase epsilon
Also known as: DAGK6, DGK, DGKE_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52429
- Gene
- DGKE
- Ensembl
- ENSG00000153933
- Chromosome
- 17
- Canonical length
- 567 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Diacylglycerol kinases are thought to be involved mainly in the regeneration of phosphatidylinositol (PI) from diacylglycerol in the PI-cycle during cell signal transduction. When expressed in mammalian cells, DGK-epsilon shows specificity for arachidonyl-containing diacylglycerol. DGK-epsilon is expressed predominantly in testis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
567 residues, UniProt reviewed canonical sequence.
>P52429|DGKE
1 MEAERRPAPG SPSEGLFADG HLILWTLCSV LLPVFITFWC SLQRSRRQLH RRDIFRKSKH
61 GWRDTDLFSQ PTYCCVCAQH ILQGAFCDCC GLRVDEGCLR KADKRFQCKE IMLKNDTKVL
121 DAMPHHWIRG NVPLCSYCMV CKQQCGCQPK LCDYRCIWCQ KTVHDECMKN SLKNEKCDFG
181 EFKNLIIPPS YLTSINQMRK DKKTDYEVLA SKLGKQWTPL IILANSRSGT NMGEGLLGEF
241 RILLNPVQVF DVTKTPPIKA LQLCTLLPYY SARVLVCGGD GTVGWVLDAV DDMKIKGQEK
301 YIPQVAVLPL GTGNDLSNTL GWGTGYAGEI PVAQVLRNVM EADGIKLDRW KVQVTNKGYY
361 NLRKPKEFTM NNYFSVGPDA LMALNFHAHR EKAPSLFSSR ILNKAVYLFY GTKDCLVQEC
421 KDLNKKVELE LDGERVALPS LEGIIVLNIG YWGGGCRLWE GMGDETYPLA RHDDGLLEVV
481 GVYGSFHCAQ IQVKLANPFR IGQAHTVRLI LKCSMMPMQV DGEPWAQGPC TVTITHKTHA
541 MMLYFSGEQT DDDISSTSDQ EDIKATELocalizationUniProt · AlphaFold · HPA
Whether an antibody against DGKE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- retina: 32 nTPM
- cerebellum: 11 nTPM
- thymus: 9.1 nTPM
- spleen: 6.5 nTPM
- endometrium: 6.1 nTPM
- testis: 6.1 nTPM
Single-cell type
- retinal bipolar cells: 243 nCPM
- rod photoreceptor cells: 213 nCPM
- cone photoreceptor cells: 159 nCPM
- lactotrophs: 119 nCPM
- bergmann glia: 98 nCPM
- brain inhibitory neurons: 92 nCPM
Immune cell
- T-reg: 1.7 nTPM
- gdT-cell: 1 nTPM
- memory B-cell: 0.9 nTPM
- naive CD8 T-cell: 0.9 nTPM
- plasmacytoid DC: 0.8 nTPM
- MAIT T-cell: 0.7 nTPM
Brain region
- cerebellum: 25 nTPM
- hypothalamus: 22 nTPM
- choroid plexus: 22 nTPM
- cerebral cortex: 20 nTPM
- basal ganglia: 19 nTPM
- white matter: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DGKE.
Disease | AllUniProt
Conditions DGKE is implicated in, by any mechanism.
- Nephrotic syndrome 7 (NPHS7) MIM:615008
- Hemolytic uremic syndrome, atypical, 7 (AHUS7) MIM:615008
Disease | GeneticClinVar
59 pathogenic / likely-pathogenic of 352 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Atypical hemolytic-uremic syndrome
- Immunoglobulin-mediated membranoproliferative glomerulonephritis
- Mesangiocapillary glomerulonephritis
- Hemolytic uremic syndrome, atypical, susceptibility to, 7
- Nephrotic syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- diacylglycerol metabolic process
- glycerolipid metabolic process
- intracellular signal transduction
- lipid phosphorylation
- modulation of chemical synaptic transmission
- phosphatidic acid biosynthetic process
- phosphatidylinositol biosynthetic process
- phospholipase C-activating G protein-coupled receptor signaling pathway
- platelet activation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Diacylglycerol kinase, accessory domain
- Diacylglycerol kinase, catalytic domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- NAD kinase/diacylglycerol kinase-like domain superfamily
- Inorganic polyphosphate/ATP-NAD kinase, N-terminal
- Diacylglycerol kinase
- C1-like domain superfamily
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Diacylglycerol kinase accessory domain
- Diacylglycerol kinase catalytic domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DGKE as an antibody target. Whether an autoantibody or antibody against DGKE could matter depends on whether native DGKE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DGKE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DGKE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...